Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digibind in Severe Preeclampsia
NCT00158743Phase 2Completed
- Sponsor
- Bio-Technology General
- Start
- Feb 2004
- Primary completion
- Dec 2007
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in preeclampsia comparing Digibind with Placebo (2 arms). Primary endpoint: Change in Creatinine Clearance. Started Feb 2004; status: completed.
02
Drugs
digoxin immune fab
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT00158743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158743.